Home

Monash University’s world-class research infrastructure is available to researchers, industry, and collaborators through an open-access model. Our platforms and facilities span diverse disciplines — from drug discovery and biomedical innovation to advanced manufacturing, materials science, and digital technologies — and are supported by expert staff who help translate ideas into impact. Whether you are an academic, industry partner, or community collaborator, you can access the tools and expertise needed to accelerate discovery and innovation.

Monash platforms and facilities bring together world-class capabilities and expertise in drug discovery, biomedical research, advanced manufacturing, and digital technologies - capabilities that enable breakthroughs and global impact.

Drug Discovery & Development

Spanning target identification through to candidate optimisation, our capability drives the journey from fundamental biology to translational discovery, helping deliver the medicines of tomorrow.

Biomedical & Life Sciences

Our biomedical capabilities provide cutting-edge technologies for imaging, genomics, phenotyping, and molecular analysis. They enable breakthroughs in health, disease, and medical technology development - driving innovations that improve lives.

Advanced Manufacturing & Materials

Harnessing next-generation fabrication, nanotechnology, microscopy, and characterisation tools, our capabilities push the boundaries of materials science and engineering. From aerospace alloys to bespoke biomedical implants, we deliver industry-ready solutions.

Digital Research

Enabling and accelerating research discovery at Monash University and beyond, through the application of advanced computing, data informatics, tools and infrastructure, all delivered at scale and built with a co-design principle between researchers and technologists.

Melbourne’s Crown as Innovation Capital is At Risk

Melbourne’s global leadership in research and innovation has been built on sustained investment in critical research infrastructure. As key facilities approach the end of their lifecycle, coordinated reinvestment will be essential to maintain capability, support discovery, and protect Victoria’s competitive edge.

A long-term co-investment approach aligned with national research infrastructure priorities will be critical to ensuring Melbourne continues to deliver research, industry and community impact.

Read the full article →

Success Stories

MAVERIC

Monash’s $60m MAVERIC AI supercomputer, the first of its kind in Australian higher education is transforming national research by enabling major advances in health, science and engineering, while running on renewable energy to support net zero goals.

Global Technician Commitment

Monash is the second Australian university to sign the UK Technician Commitment, boosting visibility, recognition, career development and sustainability for technical staff, strengthening support and ensuring world-class research continues to thrive.

Partnerships with Seer and Thermo Fisher Scientific

Monash’s Proteomics & Metabolomics Platform is advancing multiomics through new partnerships with Seer and Thermo Fisher Scientific, adding cutting-edge Proteograph XT and Orbitrap Astral MS technologies to boost discovery and translational research.

Nikon Centre of Excellence

Monash and Nikon have created Australia’s first Nikon Centre of Excellence, bringing next-gen light microscopy to campus and strengthening imaging research and training across the Monash Medical Centre, The Alfred, and the Clayton imaging facilities.

Monash advancing medical breakthroughs with Victoria’s most advanced MRI scanner

Monash University launches Victoria’s most advanced, research-dedicated MRI scanner to support world-class researchers as they accelerate breakthroughs in critical health challenges like dementia, schizophrenia, addiction, epilepsy and cancer.

Monash researchers awarded up to $22.4M for world-first lymphatic medicine

Monash researchers secured up to $22.4M AUD to develop world-first oral medicines that restore lymphatic pumping. This breakthrough aims to treat the root cause of lymphedema and chronic inflammatory diseases like arthritis.

The hidden clues in blood and individual cells are coming into view

MPMP, with Thermo Fisher Scientific, is using Orbitrap Astral mass spectrometry to reveal hidden molecular signals in blood and single cells, enabling deeper disease insights and helping identify new drug targets and diagnostics.